BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Deals

  Nyer Medical Group, Inc. Announces Sale of Company’s Florida Medical-Surgical Division

  July 9, 2008

   · 

  3 min read
• Business

  Metabolex, Inc. Names Zhao, Martin to Executive Posts

  July 9, 2008

   · 

  2 min read
• Business

  SinoFresh Healthcare Partners With Beneficial HealthCare Expanding Operations to California With New Office

  July 9, 2008

   · 

  1 min read
• Drug Development

  FDA (JOBS) Grants Epeius Biotechnologies Corporation’ Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas

  July 9, 2008

   · 

  3 min read
• Drug Development

  Cerimon Pharmaceuticals, Inc. Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis

  July 9, 2008

   · 

  3 min read
• Drug Development

  Ardea Biosciences, Inc. Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout

  July 9, 2008

   · 

  6 min read
• Business

  Invitrogen Corporation Sets Second Quarter Earnings Release Date for Thursday, July 24, 2008

  July 9, 2008

   · 

  1 min read
• Drug Development

  Introgen Therapeutics, Inc. to Host Conference Call with Clinical Investigators to Discuss Phase III Data and ADVEXIN Registration Activities

  July 9, 2008

   · 

  1 min read
• Business

  Depomed, Inc. Achieves Tier 2 Reimbursement Status for Glumetza® with CVS Caremark

  July 9, 2008

   · 

  1 min read
• Business

  Humana, Inc. Names Mark El-Tawil Market President of Arizona

  July 9, 2008

   · 

  1 min read